Prabodh K. Kandala

发表

Diindolylmethane-mediated Gli1 Protein Suppression Induces Anoikis in Ovarian Cancer Cells in Vitro and Blocks Tumor Formation Ability in Vivo*

Sanjay K. Srivastava, S. Srivastava, Prabodh K. Kandala, 2012, The Journal of Biological Chemistry.

Structure-toxicity relationship of phenolic analogs as anti-melanoma agents: an enzyme directed prodrug approach.

S. Srivastava, M. Moridani, Prabodh K. Kandala, 2010, Chemico-biological interactions.

The role of K-Ras gene mutation in TRAIL-induced apoptosis in pancreatic and lung cancer cell lines

S. Batra, S. Srivastava, R. Sahu, 2011, Cancer Chemotherapy and Pharmacology.

Regulation of Janus-activated kinase-2 (JAK2) by diindolylmethane in ovarian cancer in vitro and in vivo.

Prabodh K. Kandala, S. Srivastava, P. K. Kandala, 2012, Drug discoveries & therapeutics.

Inhibition of EGFR-AKT Axis Results in the Suppression of Ovarian Tumors In Vitro and in Preclinical Mouse Model

S. Srivastava, Parul Gupta, Sivakumar Loganathan, 2012, PloS one.

Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3)

S. Srivastava, Prabodh K. Kandala, P. K. Kandala, 2012, BMC Medicine.

Benzyl Isothiocyanate–Mediated Inhibition of Histone Deacetylase Leads to NF-κB Turnoff in Human Pancreatic Carcinoma Cells

S. Batra, S. Srivastava, R. Sahu, 2010, Molecular Cancer Therapeutics.

Molecular Cancer Therapeutics Benzyl Isothiocyanate – Mediated Inhibition of Histone Deacetylase Leads to NF-κ B Turnoff in Human Pancreatic Carcinoma Cells

S. Batra, S. Srivastava, R. Sahu, 2010 .

Blocking Epidermal Growth Factor Receptor Activation by 3,3′-Diindolylmethane Suppresses Ovarian Tumor Growth In Vitro and In Vivo

S. Srivastava, S. Wright, Prabodh K. Kandala, 2012, Journal of Pharmacology and Experimental Therapeutics.

Regulation of macroautophagy in ovarian cancer cells in vitro and in vivo by controlling Glucose regulatory protein 78 and AMPK

S. Srivastava, Prabodh K. Kandala, P. K. Kandala, 2012, Oncotarget.

Activation of Checkpoint Kinase 2 by 3,3′-Diindolylmethane Is Required for Causing G2/M Cell Cycle Arrest in Human Ovarian Cancer Cells

S. Srivastava, Prabodh K. Kandala, P. K. Kandala, 2010, Molecular Pharmacology.